Correction to " N-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms"
J Med Chem. 2021 Feb 25;64(4):2310.
doi: 10.1021/acs.jmedchem.1c00198.
Epub 2021 Feb 16.